Towards Healthcare
Drug Discovery as a Service Market 2025 Rises at 14.17% CAGR

Drug Discovery as a Service Market Grows as Pharma Giants & Startups Collaborate on AI-Powered Solutions

Market insights predict, the drug discovery as a service industry is expected to grow from USD 21.3 billion in 2024 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer occurrence as well as growing drug discoveries for chronic diseases. North America led the market due to the presence of advanced industries.

Content

  • Insight Code: 5817
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The drug discovery as a service market is projected to reach USD 79.82 billion by 2034, growing at a CAGR of 14.17% from 2024 to 2034.

North America is currently leading the drug discovery as a service market due to the presence of advanced industries

The drug discovery as a service market includes five segments such as by service type, Shape, Picture by technology, by end user, by therapeutic area, and by region

Some key players include Charles River Laboratories, WuXi AppTec, Evotec AG, and Covance (Labcorp).

Key trends include growing innovations in next-generation molecular modeling platforms for drug discovery, and discovering and developing new oral candidates to treat diseases across multiple chronic indications.

Drug Discovery as a Service (DDaaS) is a business model where pharmaceutical, biotech, and academic organizations outsource various stages of the drug discovery process to specialized external providers

Increasing cancer incidences are the factor that drives the market.

American Cancer Society, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions